产品标题 |
产品货号 |
产品规格 |
厂家 |
Human DNA: Lung; Pneumonia, post-obstructive from ORIGENE TECHNOLOGIES | CD564383 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Lung; Pneumonia, post-obstructive from ORIGENE TECHNOLOGIES | CD565161 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Lung; Pneumonia, post-obstructive from ORIGENE TECHNOLOGIES | CD564863 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Lung; Pneumonia, post-obstructive from ORIGENE TECHNOLOGIES | CD565223 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Lung; Pneumonia, post-obstructive from ORIGENE TECHNOLOGIES | CD565169 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Lung; Pneumonia, post-obstructive from ORIGENE TECHNOLOGIES | CD565332 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Lung; Pneumonia, post-obstructive from ORIGENE TECHNOLOGIES | CD565238 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Lung; Pneumonitis from ORIGENE TECHNOLOGIES | CD563938 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Lung; Pneumonitis from ORIGENE TECHNOLOGIES | CD563939 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Lung; Pneumonitis from ORIGENE TECHNOLOGIES | CD564898 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Lung; Pneumonitis, chronic from ORIGENE TECHNOLOGIES | CD563092 | 5 ug | ORIGENE TECHNOLOGIES |
Human DNA: Lung; Pneumonitis, chronic from ORIGENE TECHNOLOGIES | CD563333 | 5 ug | ORIGENE TECHNOLOGIES |
Human synaptopodin 2-like (SYNPO2L), transcript variant 1 from ORIGENE TECHNOLOGIES | TP326285 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptopodin (SYNPO), transcript variant 3. from ORIGENE TECHNOLOGIES | TP328616 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptoporin (SYNPR), transcript variant 2 from ORIGENE TECHNOLOGIES | TP305424 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptoporin (SYNPR), transcript variant 1 from ORIGENE TECHNOLOGIES | TP325395 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptosomal-associated protein, 91kDa homolog (mouse) (SNAP91), transcript variant 1 from ORIGENE TECHNOLOGIES | TP322020 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptosomal-associated protein, 29kDa (SNAP29) from ORIGENE TECHNOLOGIES | TP302179 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptosomal-associated protein, 23kDa (SNAP23), transcript variant 1 from ORIGENE TECHNOLOGIES | TP301596 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptosomal-associated protein, 25kDa (SNAP25), transcript variant 1 from ORIGENE TECHNOLOGIES | TP302068 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptosomal-associated protein, 25kDa (SNAP25), transcript variant 2 from ORIGENE TECHNOLOGIES | TP312596 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptotagmin III (SYT3) from ORIGENE TECHNOLOGIES | TP305963 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptotagmin III (SYT3), transcript variant 2. from ORIGENE TECHNOLOGIES | TP328969 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptotagmin III (SYT3), transcript variant 3. from ORIGENE TECHNOLOGIES | TP328970 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptotagmin II (SYT2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP326544 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptotagmin I (SYT1), transcript variant 2 from ORIGENE TECHNOLOGIES | TP327105 | 20 ug | ORIGENE TECHNOLOGIES |
Human synaptotagmin I (SYT1), transcript variant 3 from ORIGENE TECHNOLOGIES | TP327252 | 20 ug | ORIGENE TECHNOLOGIES |
Regulator of G-protein signaling 14 (RGS14) from ORIGENE TECHNOLOGIES | LY416615 | 100 ug | ORIGENE TECHNOLOGIES |
Regulator of G-protein signaling 16 (RGS16) from ORIGENE TECHNOLOGIES | LY419009 | 100 ug | ORIGENE TECHNOLOGIES |
Regulator of G-protein signaling 17 (RGS17) from ORIGENE TECHNOLOGIES | LY402209 | 100 ug | ORIGENE TECHNOLOGIES |
Regulator of G-protein signaling 18 (RGS18) from ORIGENE TECHNOLOGIES | LY408941 | 100 ug | ORIGENE TECHNOLOGIES |
Regulator of G-protein signaling 21 (RGS21) from ORIGENE TECHNOLOGIES | LY422023 | 100 ug | ORIGENE TECHNOLOGIES |
Regulator of G-protein signaling 5 (RGS5) from ORIGENE TECHNOLOGIES | LY418548 | 100 ug | ORIGENE TECHNOLOGIES |
Regulator of G-protein signaling 6 (RGS6) from ORIGENE TECHNOLOGIES | LY418086 | 100 ug | ORIGENE TECHNOLOGIES |
Regulator of G-protein signaling 7 (RGS7) from ORIGENE TECHNOLOGIES | LY419005 | 100 ug | ORIGENE TECHNOLOGIES |
Syncollin (SYCN) from ORIGENE TECHNOLOGIES | LY420725 | 100 ug | ORIGENE TECHNOLOGIES |
SYNCRIP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417902 | 1 kit | ORIGENE TECHNOLOGIES |
Syncrip - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN517053 | 1 kit | ORIGENE TECHNOLOGIES |
Syndecan binding protein (syntenin) (SDCBP), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417182 | 100 ug | ORIGENE TECHNOLOGIES |
Syndecan binding protein (syntenin) (SDCBP), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425198 | 100 ug | ORIGENE TECHNOLOGIES |
Syndecan binding protein (syntenin) (SDCBP), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423571 | 100 ug | ORIGENE TECHNOLOGIES |
Syndecan binding protein (syntenin) (SDCBP), transcript variant 3 from ORIGENE TECHNOLOGIES | LY423572 | 100 ug | ORIGENE TECHNOLOGIES |
Syndecan binding protein (syntenin) (SDCBP), transcript variant 3 from ORIGENE TECHNOLOGIES | LY425199 | 100 ug | ORIGENE TECHNOLOGIES |
Human syncoilin, intermediate filament protein (SYNC), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP710120 | 20 ug | ORIGENE TECHNOLOGIES |
Human syndecan binding protein (syntenin) (SDCBP), transcript variant 1 from ORIGENE TECHNOLOGIES | TP315390 | 20 ug | ORIGENE TECHNOLOGIES |
Human syndecan binding protein (syntenin) 2 (SDCBP2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP318898 | 20 ug | ORIGENE TECHNOLOGIES |
Human syndecan binding protein (syntenin) (SDCBP), transcript variant 3 from ORIGENE TECHNOLOGIES | TP315442 | 20 ug | ORIGENE TECHNOLOGIES |
Human syndecan binding protein (syntenin) (SDCBP), transcript variant 2 from ORIGENE TECHNOLOGIES | TP312681 | 20 ug | ORIGENE TECHNOLOGIES |
Human syndecan binding protein (syntenin) (SDCBP), transcript variant 5 from ORIGENE TECHNOLOGIES | TP720983 | 10 ug | ORIGENE TECHNOLOGIES |
Rat IGFBP5 ELISA Kit from ORIGENE TECHNOLOGIES | EA100773 | 8x12 divisible strip | ORIGENE TECHNOLOGIES |